A few-port inflatable robot-assisted thoracoscopic surgery for mediastinal tumor is feasible and trusted it is more advantageous, and it provides the surgeon with suggestions on therapy preference.Future, multicentre randomised controlled trials to evaluate efficacy, extended-phrase outcomes, safety and price are the next steps in advance of preval